The Hong Kong-based provider of pain relief services using traditional Chinese principles aims to raise about $7.2 million through its U.S. listing, valuing it at up to $200 millionKey Takeaways:Anew Health has filed for a U.S. IPO, aiming to sell investors on its use of techniques based on traditional Chinese medicine principles to treat painThe Hong Kong-based company plans to raise about $7.2 million, about half earmarked for expanding both at home and in other markets with big Asian populationsTradition ...

Revenue miss - 1H25 revenue decreased by 4.8% (-7.5% vs. GSe), and net profits also missed at Rmb1,442mn (-16.2% yoy, -16.2% vs. GSe). Its core revenue (hepatic disease medication) still grew by 9.7% yoy despite weak consumption power, while total revenue missed mainly due to revenue decrease from distribution (-13% yoy) and cosmetics & personal goods (-17% yoy). Earnings miss - 1H25 net profits also missed, attributed to higher raw material cost in 1H25, resulting in GPM of hepatic disease medication decre ...

Hello everyone, my name is Renley. Today I want to talk about the collision between artificial intelligence with traditional Chinese medicine. What if I told you that in the climate right now an AI is analyzing tone coding with picture perfect precision.Can you imagine the spark when silver needles with horrible medicine with uh artificial intelligence. This is the age where old wisdom meets tomorrow's tools and it's happening right around us. My grandma has old medicine chest at home.The herbs and fork rem ...

From koji-making to pharmaceutical preparation, from the differentiation of yin and yang to the transformation of the five elements, traditional Chinese medicine (TCM) and Chinese culture have been influencing generations of Chinese people. With accessible principles and stories, Dr. WEN Junkai painted a vivid picture of the endless vitality of nature and the harmonious transformation of all things in the universe, along with their philosophical underpinnings. He also affirmed the necessity of integrating t ...

Singapore will gradually integrate more traditional Chinese medicine treatments into its public healthcare system to explore how such therapies could complement Western ones. https://t.co/wSufeObJeZ ...

Regencell Bioscience Holdings Ltd. RGC, a Hong Kong-based biotech startup with no reported revenue, has gained more than 59,000% in 2025. The company, which claims to be developing traditional Chinese herbal treatments for childhood ADHD and autism, saw its market value reach nearly $30 billion, by Monday's close. Following a 38-for-1 stock split announced earlier in June, the stock skyrocketed by over 280% on Monday.Read Next: Sunrun, First Solar Plunge—Solar Stocks Hit Hard By Trump Tax Bill: Latest Regen ...

Regencell CEO Yat-Gai Au controls 86.24% of the total number of shares outstanding, according to FactSet data.The company's year to date performance is off the charts too, having risen 46,000% in 2025. By Monday's close, Regencell, founded in 2014 and traded on Nasdaq under the ticker 'RGC' since 2021, had a total market capitalization of $29.7 billion, according to S&P Capital IQ.Shares of Regencell, which says it develops traditional Chinese herb treatments to treat childhood attention deficit hyperactivi ...